Isoform-specific vs. pan-histone deacetylase inhibition as approaches for countering glioblastoma: an in vitro study

IntroductionGlioblastoma (GBM) is a grade 4 brain tumor that originates in astrocytes. GBM has a high death rate and a very low median patient survival rate of 14–16 months, even with well-established treatment regimens. The majority of preclinical models assess the effectiveness of molecular leads...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ameya Joshi, Natasha Ratnapradipa, Jayce Hughes, Erik Moore, Andrew Ekpenyong, Surabhi Shukla
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-11-01
coleção:	Frontiers in Oncology
Assuntos:	glioblastoma HDAC inhibitors Vorinostat Trichostatin-A Tubacin temozolomide
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1695552/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!